In the complex tapestry of leadership, awareness isn’t just a desirable trait; it’s the bedrock upon which success is built. It’s the lens through which leaders perceive, interpret, and navigate the ever-shifting landscape of their organizations and industries. Without it,…
COMMENTARY
Kudos to MHLW for Creating New Confab, but 1st Meeting Stirs Industry Frustration
By Takashi Ohama The Ministry of Health, Labor and Welfare (MHLW) set up a new public-private dialogue (kanmin taiwa) confab in April as a venue to discuss drug pricing reforms. While the move was generally welcomed by the pharmaceutical industry,…
To read the full story
COMMENTARY
- The Price of Stability: Who Bears Japan’s Drug Distribution Burden?
October 27, 2025
- Inside Eylea - 2: Will a Bio-AG Return after Six Years? Pricing Debate Resumes
October 7, 2025
- Inside Eylea - 1: Patent Issues Behind Differences in Biosimilar Indications for AMD and DME
October 6, 2025
- FPMAJ Chair’s Call for Blanket Drug Price Hike: Bold Pitch or Wild Throw?
September 30, 2025
- MHLW Grows Jittery over Supply Risks amid Rising Foreign Investments
September 8, 2025





